Latest News
| U.S. Food and Drug Administration Approves Cayston® (aztreonam for inhalation solution) 75 mg | ![]() |
News
- Read Gilead's 2008 Annual Report
- Gilead Sciences to Present at the Cowen and Company 30th Annual Health Care Conference on Thursday, March 11
- U.S. Food and Drug Administration Approves Cayston(R) (Aztreonam for Inhalation Solution) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa
- Gilead's Single-Tablet "Quad" Regimen for HIV Achieves a High Rate of Virologic Suppression in Phase II Study
- View all news
Events
- March 16 - 18, 2010
American College of Cardiology
Atlanta, GA - March 23 - 24, 2010
Barclay’s Capital 2010 Global Healthcare Conference
Miami, FL - View all events



